Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review

被引:8
|
作者
Layard Horsfall, Hugo [1 ,2 ,3 ,4 ]
Lawrence, Alistair [5 ]
Venkatesh, Ashwin
Loh, Ryan T. S.
Jayapalan, Ronie [1 ,2 ]
Koulouri, Olympia [6 ,7 ,8 ,9 ]
Sharma, Rishi [2 ,10 ]
Santarius, Thomas [1 ,2 ]
Gurnell, Mark [6 ,7 ,8 ,9 ]
Dorward, Neil [3 ]
Mannion, Richard [1 ,2 ]
Marcus, Hani J. [3 ,4 ]
Kolias, Angelos G. [1 ,2 ]
机构
[1] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England
[2] Univ Cambridge, Cambridge, England
[3] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Queen Sq, London W1CN 3BG, England
[4] UCL, Wellcome EPSRC Ctr Intervent & Surg Sci, London, England
[5] Royal London Hosp, Dept Neurosurg, London, England
[6] Univ Cambridge, Clin Sch Med, Cambridge, England
[7] Inst Metab Sci, Metab Res Labs, Cambridge, England
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Addenbrookes Hosp, Cambridge, England
[10] Addenbrookes Hosp, Dept Otolaryngol, Cambridge, England
基金
英国惠康基金; 英国工程与自然科学研究理事会;
关键词
Neurosurgery; Pituitary; Transsphenoidal; Outcome; Adenoma; Core outcome sets; INSTITUTE;
D O I
10.1007/s11102-023-01303-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeTranssphenoidal surgery is an established treatment for pituitary adenomas. We examined outcomes and time points following transsphenoidal surgery for pituitary adenoma to identify reporting heterogeneity within the literature.MethodsA systematic review of studies that reported outcomes for transsphenoidal surgery for pituitary adenoma 1990-2021 were examined. The protocol was registered a priori and adhered to the PRISMA statement. Studies in English with > 10 patients (prospective) or > 500 patients (retrospective) were included.Results178 studies comprising 427,659 patients were included. 91 studies reported 2 or more adenoma pathologies within the same study; 53 studies reported a single pathology. The most common adenomas reported were growth hormone-secreting (n = 106), non-functioning (n = 101), and ACTH-secreting (n = 95); 27 studies did not state a pathology. Surgical complications were the most reported outcome (n = 116, 65%). Other domains included endocrine (n = 104, 58%), extent of resection (n = 81, 46%), ophthalmic (n = 66, 37%), recurrence (n = 49, 28%), quality of life (n = 25, 19%); and nasal (n = 18, 10%). Defined follow up time points were most reported for endocrine (n = 56, 31%), extent of resection (n = 39, 22%), and recurrence (n = 28, 17%). There was heterogeneity in the follow up reported for all outcomes at different time points: discharge (n = 9), < 30 days (n = 23), < 6 months (n = 64), < 1 year (n = 23), and > 1 year (n = 69).ConclusionOutcomes and follow up reported for transsphenoidal surgical resection of pituitary adenoma are heterogenous over the last 30 years. This study highlights the necessity to develop a robust, consensus-based, minimum, core outcome set. The next step is to develop a Delphi survey of essential outcomes, followed by a consensus meeting of interdisciplinary experts. Patient representatives should also be included. An agreed core outcome set will enable homogeneous reporting and meaningful research synthesis, ultimately improving patient care.
引用
收藏
页码:171 / 181
页数:11
相关论文
共 50 条
  • [1] Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review
    Hugo Layard Horsfall
    Alistair Lawrence
    Ashwin Venkatesh
    Ryan T. S. Loh
    Ronie Jayapalan
    Olympia Koulouri
    Rishi Sharma
    Thomas Santarius
    Mark Gurnell
    Neil Dorward
    Richard Mannion
    Hani J. Marcus
    Angelos G. Kolias
    Pituitary, 2023, 26 : 171 - 181
  • [2] Transsphenoidal and transcranial surgery for pituitary adenomas
    Couldwell, WT
    JOURNAL OF NEURO-ONCOLOGY, 2004, 69 (1-3) : 237 - 256
  • [3] Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis
    Yu, Shi-Yuan
    Du, Qiu
    Yao, Si-Yuan
    Zhang, Ke-Nan
    Wang, Jian
    Zhu, Zhe
    Jiang, Xiao-Bing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (03) : 2023 - 2027
  • [4] Transsphenoidal and Transcranial Surgery for Pituitary Adenomas
    William T. Couldwell
    Journal of Neuro-Oncology, 2004, 69 : 237 - 256
  • [5] Purely Endoscopic Transsphenoidal Surgery versus Traditional Microsurgery for Resection of Pituitary Adenomas: Systematic Review
    Strychowsky, Julie
    Nayan, Smriti
    Reddy, Kesava
    Farrokhyar, Forough
    Sommer, Doron
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2011, 40 (02): : 175 - 185
  • [6] Outcomes of Transsphenoidal Surgery in Growth Hormone-Secreting Pituitary Adenomas
    Voznyak, Oleksandr
    Lytvynenko, Andrii
    Maydannyk, Oleg
    Ilyuk, Roman
    Zinkevych, Yaroslav
    Hryniv, Nazarii
    INDIAN JOURNAL OF NEUROSURGERY, 2021, 10 (01) : 61 - 64
  • [7] Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis
    Drexler, Richard
    Rotermund, Roman
    Smith, Timothy R.
    Kilgallon, John L.
    Honegger, Juergen
    Nasi-Kordhishti, Isabella
    Gardner, Paul A.
    Gersey, Zachary C.
    Abdallah, Hussein M.
    Jane, John A., Jr.
    Marino, Alexandria C.
    Knappe, Ulrich J.
    Uksul, Nesrin
    Rzaev, Jamil A.
    Galushko, Evgeniy V.
    Gormolysova, Ekaterina V.
    Bervitskiy, Anatoliy V.
    Schroeder, Henry W. S.
    Eoerdoegh, Marton
    Losa, Marco
    Mortini, Pietro
    Gerlach, Ruediger
    Azab, Mohammed
    Budohoski, Karol P.
    Rennert, Robert C.
    Karsy, Michael
    Couldwell, William T.
    Antunes, Apio C. M.
    Westphal, Manfred
    Ricklefs, Franz L.
    Flitsch, Joerg
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2023, 189 (03) : 379 - 386
  • [8] Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study
    Paja, Miguel
    Soto, Alfonso
    Hanzu, Felicia A.
    Guerrero-Perez, Fernando
    Camara, Rosa
    Moure, Dolores
    Galvez, Angeles
    Simo-Servat, Andreu
    Villar-Taibo, Rocio
    Calatayud, Maria
    Vicente, Almudena
    Recio-Cordova, Jose M.
    Serra, Guillermo
    Martin Rojas-Marcos, Patricia
    Parra-Ramirez, Paola
    Araujo-Castro, Marta
    Librizzi, Soledad
    Irigaray, Ana
    Ollero, Dolores
    Aznar, Silvia
    Munoz, Fernando
    Aulinas, Anna
    Gonzalez-Fernandez, Laura
    Garcia-Centeno, Rogelio
    Egana, Nerea
    Gonzalez-Vidal, Tomas
    Menendez, Edelmiro
    Delgado, Ana M.
    Abarca, Javier
    Sottile, Johana
    Pico, Antonio M.
    Novo, Cristina
    Ortiz, Isabel
    Tenorio, Carmen
    de Leon, Ricardo
    de Pablos-Velasco, Pedro
    Crespo, Cristina
    Penalver, David
    Diaz-Soto, Gonzalo
    Puig-Domingo, Manel
    Biagetti, Betina
    Neuroendocrinology Grp Spanish Endocrinol Nutr Soc SEEN
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [9] Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas
    Pietro Mortini
    Endocrine, 2014, 47 : 415 - 420
  • [10] Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas
    Mortini, Pietro
    ENDOCRINE, 2014, 47 (02) : 415 - 420